Simplifying the TNM system for clinical use in differentiated thyroid cancer

Journal of Clinical Oncology

Volumn 27, Issue 11, 2009, Pages 1872-1878

  Doi, Suhail A R ^a   Onitilo, Adedayo A ^a   Engel, Jessica M ^a   Lundgren, Catharina Ihre ^a   Hall, Per ^a   Thalib, Lukman ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ELECTRONIC MEDICAL RECORD; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ALTERNATIVE TO THE TNM SYSTEM; SCORING SYSTEM; THYROID FOLLICULAR CARCINOMA; VALIDATION STUDY;

ADULT; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; THYROID NEOPLASMS;

EID: 64649086920     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.20.2382     Document Type: Article

References (35)

1. Burke HB, Henson DE: The American Joint Committee on Cancer: Criteria for prognostic factors and for an enhanced prognostic system. Cancer 72:3131-3135, 1993
2. Burke HB: Outcome prediction and the future of the TNM staging system. J Natl Cancer Inst 96:1408-1409, 2004
3. Hermanek P, Sobin LH, Wittekind C: How to improve the present TNM staging system. Cancer 86:2189-2191, 1999
4. Lundgren CI, Hall P, Dickman PW, Zedenius J: Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer. Br J Surg 94:571-577, 2007
5. Greenlee RT: Measuring disease frequency in the Marshfield Epidemiologic Study Area (MESA). Clin Med Res 1:273-280, 2003
6. Wilke RA, Berg RL, Peissig P, et al: Use of an electronic medical record for the identification of research subjects with diabetes mellitus. Clin Med Res 5:1-7, 2007
7. Hay ID, Bergstralh EJ, Goellner JR, et al: Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1057, 1993; discussion 1057-1058, 1993
8. Shaha AR: TNM classification of thyroid carcinoma. World J Surg 31:879-887, 2007
9. Wada N, Nakayama H, Suganuma N, et al: Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J Clin Endocrinol Metab 92:215-218, 2007
10. Passler C, Prager G, Scheuba C, et al: Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution. Ann Surg 237:227-234, 2003
11. Lang BH, Lo CY, Chan WF, et al: Staging systems for papillary thyroid carcinoma: A review and comparison. Ann Surg 245:366-378, 2007
12. Beenken S, Roye D, Weiss H, et al: Extent of surgery for intermediate-risk well-differentiated thyroid cancer. Am J Surg 179:51-56, 2000
13. Jukkola A, Bloigu R, Ebeling T, et al: Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications. Endocr Relat Cancer 11:571-579, 2004
14. Byar DP, Green SB, Dor P, et al: A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. Eur J Cancer 15:1033-1041, 1979
15. Cady B, Rossi R: An expanded view of risk- group definition in differentiated thyroid carcinoma. Surgery 104:947-953, 1988
16. DeGroot LJ, Kaplan EL, McCormick M, et al: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424, 1990
17. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428, 1994
18. Shaha AR, Loree TR, Shah JP: Intermediate-risk group for differentiated carcinoma of thyroid. Surgery 116:1036-1040, 1994; discussion 1040-1041, 1994
19. Lerch H, Schober O, Kuwert T, et al: Survival of differentiated thyroid carcinoma studied in 500 patients. J Clin Oncol 15:2067-2075, 1997
20. Hay ID, Grant CS, Taylor WF, et al: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095, 1987
21. Pasieka JL, Zedenius J, Auer G, et al: Addition of nuclear DNA content to the AMES risk-group classification for papillary thyroid cancer. Surgery 112:1154-1159, 1992; discussion 1159-1160, 1992
22. Akslen LA: Prognostic importance of histologic grading in papillary thyroid carcinoma. Cancer 72:2680-2685, 1993
23. Noguchi S, Murakami N, Kawamoto H: Classification of papillary cancer of the thyroid based on prognosis. World J Surg 18:552-557, 1994; discussion 558, 1994
24. Sherman SI, Brierley JD, Sperling M, et al: Prospective multicenter study of thyroid carcinoma treatment: Initial analysis of staging and outcome: National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83:1012-1021, 1998
25. Sebastian SO, Gonzalez JM, Paricio PP, et al: Papillary thyroid carcinoma: Prognostic index for survival including the histological variety. Arch Surg 135:272-277, 2000
26. Sugitani I, Kasai N, Fujimoto Y, et al: A novel classification system for patients with PTC: Addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139-148, 2004
27. Yildirim E: A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. J Am Coll Surg 200:378-392, 2005
28. Lundgren CI, Hall P, Dickman PW, et al: Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 106:524-531, 2006
29. Passler C, Scheuba C, Prager G, et al: Prognostic factors of papillary and follicular thyroid cancer: Differences in an iodine-replete endemic goiter region. Endocr Relat Cancer 11:131-139, 2004
30. Shaha A: Treatment of thyroid cancer based on risk groups. J Surg Oncol 94:683-691, 2006
31. Pelizzo MR, Boschin IM, Toniato A, et al: Papillary thyroid carcinoma: 35-year outcome and prognostic factors in 1858 patients. Clin Nucl Med 32:440-444, 2007
32. Sato N, Oyamatsu M, Koyama Y, et al: Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol 69:151-155, 1998
33. Beasley NJ, Lee J, Eski S, et al: Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg 128:825-828, 2002
34. Haq M, Harmer C: Differentiated thyroid carcinoma with distant metastases at presentation: Prognostic factors and outcome. Clin Endocrinol (Oxf) 63:87-93, 2005
35. Clark JR, Lai P, Hall F, et al: Variables predicting distant metastases in thyroid cancer. Laryngoscope 115:661-667, 2005